Genç TRASD retweeted
🆕 #ACR26 The Great Debate - Diagnosing Sjogren's Disease: Is Lip Biopsy Really Necessary?
🔹Role of Salivary Gland Bx for Dx
🔹Use in SSA neg patients or ruling out mimics
🔹can see focus score ≥1 in healthy populations!
#Sjogrens #SjogrensDisease #RheumX
Genç TRASD retweeted
Unilateral Renal Artery Vasculitis: A Case Report
@vasculitides @GencTRASD @anarsiknotrofil @AAuanassova @OlenaZimba
pmc.ncbi.nlm.nih.gov/article…
Genç TRASD retweeted
Reproductive health awareness and family planning practices among women with systemic autoimmune diseases: survey based study
@anarsiknotrofil @BurhanFatihKoy1 @hande_snc @ozlemkilic_md @YuliyaFedorchen @KardumZeljka @GencTRASD
link.springer.com/article/10…
Genç TRASD retweeted
Automating the triage of rheumatology outpatient referrals: a comparative evaluation of 23 large language models under simple and advanced prompting
@ArthritisAust @APLAR_org @PanlarLeague @GencTRASD @ACRheum @eular_org @DDoskaliuk @OlenaZimba
link.springer.com/article/10…
Genç TRASD retweeted
New content online: Advances in the treatment of eosinophilic granulomatosis with polyangiitis dlvr.it/TTrl8c
Genç TRASD retweeted
Scientific Writing Demystified: Systematic and Narrative Reviews - Durga Prasanna Misra, 2026
@LatikaGupta_ @sakir_rheum @PanktiMehta24 @prakashini_ @12VRavindran @OlenaZimba @DDoskaliuk @BurhanFatihKoy1 @NeslihanGken7 @GencTRASD @hande_snc
journals.sagepub.com/doi/10.…
Genç TRASD retweeted
WSF Academy Webinar on DU in SSC🎙Chair: Mercè Piñero Vegas (AEE)👩⚕️@TaniNgcozana🩹 Practical management of DU👨⚕️ Dr. Michael Hughes🩺 What must be assessed in SSc patients with DU?
🤝 In collaboration @AEEsclerodermia worldsclerofound.org/registe…
Genç TRASD retweeted
recommendations for the management of systemic sclerosis #Rheumatology 👇
New content online: Navigating evidence-based recommendations for the management of systemic sclerosis dlvr.it/TTrnzy
Genç TRASD retweeted
Unveiling hidden challenges: impaired foot posture due to skin involvement in systemic sclerosis | Cent Asian J Med Hypotheses Ethics
@NeslihanGken7 @nesecabuk @BurhanFatihKoy1 @anarsiknotrofil @Gulsandaluzun @ozlemkilic_md @GencTRASD
cajmhe.com/index.php/journal…
Genç TRASD retweeted
Psoriatic arthritis patients have increased morbidity already at the time of diagnosis: a case–control study
@psoriasis_hub @GencTRASD @hande_snc @anarsiknotrofil @BRK_QZ @Mattkliw @OlenaZimba
link.springer.com/article/10…
Genç TRASD retweeted
Home-based postural exercise as an adjunct to duloxetine improves sleep quality, physical quality of life, and trunk mobility in fibromyalgia: a randomized controlled trial
@GencTRASD @ISPRM @anarsiknotrofil @BurhanFatihKoy1 @goksu_kemer @NeslihanGken7
link.springer.com/article/10…
Genç TRASD retweeted
Cost-effectiveness of artificial intelligence interventions for musculoskeletal disorders of the spine: a systematic review
@ISPRM @JCRheum @Asoreuma @PanlarLeague @ACRheum @eular_org @GencTRASD
link.springer.com/article/10…
Genç TRASD retweeted
True or False: In a Japanese study of refractory neuropsychiatric SLE, rituximab led to significant improvement in the majority of patients treated. See if you got it right at buff.ly/4TebJFD
Genç TRASD retweeted
RheumNow’s global faculty reporters help translate the data into clinical practice.
Featuring:
✨ Dr. Janet Pope (@Janetbirdope)
✨ Dr. Yuz Yusof (@Yuz6Yusof)
✨ Dr. Jiha Lee (@JihaRheum)
✨ Dr. Mrinalini Dey (@DrMiniDey)
✨ Dr. Aurelie Najm (@AurelieRheumo)
✨ Dr. Bella Mehta (@bella_mehta)
Follow RheumNow for expert-curated #EULAR2026 coverage that matters to clinical care.🌍 Global perspectives. Real-time insights. Trusted voices.
Genç TRASD retweeted
NLRP3 inflammasome activation triggers PAD (2, 4) release from human neutrophils, increasing citrullination of intracellular proteins (CCPs) and driving the pathogenesis of #RA. Further proof: , PAD concentrations and PAD activity correlate with IL-1β.buff.ly/y6eDWy8 buff.ly/y6eDWy8
Genç TRASD retweeted
ACR is seeking individuals active on social media & excited to showcase #ACR26 by serving as an #ACRambassador. Tell the #ACR26 story to your followers & the world! 💬 DEADLINE—Tues., June 9, noon ET. DETAILS → acr.tw/3mN8AGY
Genç TRASD retweeted
NEW: The “2026 ACR Updated Recommended Methods for Development of Disease Classification and Response Criteria” highlights guiding principles, outlines a methodological approach, provides relevant examples, and emphasizes considerations for ACR funding and endorsement. View → acr.tw/42IhJ52
Genç TRASD retweeted
Late-onset systemic sclerosis: current concepts, uncertainties, and future practice guidelines
@ScleroIndia @SclerodermaRF @SclerodermaNews @SclerodermaCAN @Worldsclerofnd @JCRheum @ReumatologiaU @DGRh_Tweets @GencTRASD @eular_org @ACRheum
reu.termedia.pl/Late-onset-s…




















